Direct-To-Consumer Advertisements For HIV Antiretroviral Medications: A Progress Report
Open Access
- 1 September 2007
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 26 (5), 1392-1398
- https://doi.org/10.1377/hlthaff.26.5.1392
Abstract
Direct-to-consumer (DTC) prescription drug advertisements for HIV anti-retrovirals are controversial and have been criticized in the past for including deceptive images and underplaying HIV drug limitations. We sought to describe the state of recent DTC ads for HIV antiretrovirals in popular magazines by performing a content analysis of all complete DTC ads for antiretroviral medications appearing in eight national magazines during a one-year period. Current ads appear to have addressed previous concerns, but important problems still exist, such as failing to specify the medication’s role in current treatment, to quantify drug efficacy, or to highlight life-threatening side effects.Keywords
This publication has 9 references indexed in Scilit:
- FDA Considers Tightening Regulations for Direct-to-Consumer AdvertisingJNCI Journal of the National Cancer Institute, 2005
- A Closer Look at the Concept, Historical Overview, and Value of Direct-to-Consumer Advertising of Prescription DrugsHospital Topics, 2005
- The Value Of Benefit Data In Direct-To-Consumer Drug AdsHealth Affairs, 2004
- FDA examines direct-to-consumer advertising data.American Journal of Health-System Pharmacy, 2003
- Are HIV drug advertisements contributing to increases in risk behavior among men in San Francisco, 2001?AIDS, 2002
- Timing of New Black Box Warnings and Withdrawals for Prescription MedicationsJAMA, 2002
- Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?The Lancet, 2001
- Audit team finds further faults with doctors resultsBMJ, 2001
- From the Food and Drug AdministrationJAMA, 1997